NCT07613723: A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
- State
- Under way
- Phase
- Phase 1
- People
- 9 planned
- Started
- 11 May 2026
- Primary completion
- Dec 2028
- Arms
- ZI-MA4-1 (TCR-NK cells)
- Results
- None posted
- 11 May 2026: Trial started
- 29 May 2026: Trial registered